---  
layout: startup_page  
title: "Exsilio Therapeutics"  
id: "exsiliotx.com"  
permalink: "/exsiliotherapeuticsexsiliotx.com06252024/"  
website: "https://exsiliotx.com/"  
funding_round: "Series A"  
funding_amount: "$82M"  
investors: "Novartis Venture Fund, Delos Capital, OrbiMed, Insight Partners, J.P. Morgan Life Sciences Private Capital, CRISPR Therapeutics, Innovation Endeavors, Invus, Arc Ventures, Deep Insight"  
about: "Exsilio Therapeutics is a biotechnology company developing genomic medicines for various diseases. Their platform uses naturally occurring genetic elements delivered via mRNA and lipid nanoparticles to precisely insert genes into the human genome. This approach aims for durable and potentially curative effects for genetic diseases, cancer, and autoimmune conditions."  
markets: "Biotechnology, Genomics, mRNA Therapeutics"  
hq: "Boston, Massachusetts, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/exsiliotx"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/exsilio-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/607040-47"  

date_display: "25-Jun-2024"  
date: "2024-06-25"

# SEO Optimization  
meta_title: "Exsilio Therapeutics - Series A Funding ($82M)"  
meta_description: "Exsilio Therapeutics, Exsilio Therapeutics is a biotechnology company developing genomic medicines for various diseases. Their platform uses naturally occurring genetic ele..."  
meta_keywords: "Exsilio Therapeutics, Biotechnology, Genomics, mRNA Therapeutics, Series A funding"  
canonical_url: "https://startup.projectstartups.com/exsiliotherapeuticsexsiliotx.com06252024/"  
---